Researchers uncover how diabetic peripheral neuropathy weakens bones via disrupted cellular communication using mouse models ...

Insulin resistance can be reversed by changing your diet, adopting a healthier and balanced lifestyle, and consuming specific herbal preparations.

China: A new study, published in Diabetes, Metabolic Syndrome and Obesity, has shed light on the potential role of specific ...

Fecal microbiota analysis of pregnant women may provide early identification of those at risk for gestational diabetes.

A new study published in the Journal of Digestive Diseases found a significant increase in gallstone disease in the U.S., ...

Apart from simple diagnosis, the study takes an important step toward predictive health monitoring by modeling the risk of ...

The shares of the prominent pharmaceutical company gained up to 4 percent in today's trading session after the company ...

The first known written records of diabetes were found in Egypt around 1550 B.C., in China during the second century and in India in the fifth century. The term diabetes is shortened from the medical ...

Kirsty, Biocon's rapid-acting insulin, is the first FDA-approved interchangeable biosimilar to NovoLog in the US and will be ...

As per the company’s regulatory filing, Kristy is currently available in the European Union and Canada markets from 2022.

Biocon bagged US FDA's approval for Kristy, which is a rapid-acting human insulin analog, indicated to improve glycemic control in patients with diabetes mellitus.

Biocon Biologics receives USFDA approval for Kirsty, an interchangeable biosimilar to NovoLog, expanding their insulin ...